Format
Sort by
Items per page

Send to

Choose Destination

Best matches for atherosclerosis chlamydia pneumoniae:

Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis. Filardo S et al. Mediators Inflamm. (2015)

Chlamydia pneumoniae and progression of subclinical atherosclerosis. Player MS et al. Eur J Prev Cardiol. (2014)

CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice. Zafiratos MT et al. Pathog Dis. (2015)

Search results

Items: 1 to 20 of 1143

1.

Role of vasodilator-stimulated phosphoprotein in human cytomegalovirus-induced hyperpermeability of human endothelial cells.

Tian Y, He Y, Zhang L, Zhang J, Xu L, Ma Y, Xu X, Wei L.

Exp Ther Med. 2018 Aug;16(2):1295-1303. doi: 10.3892/etm.2018.6332. Epub 2018 Jun 20.

2.

Intranasal immunization with recombinant chlamydial protease-like activity factor attenuates atherosclerotic pathology following Chlamydia pneumoniae infection in mice.

Li W, Gudipaty P, Li C, Henderson KK, Ramsey KH, Murthy AK.

Immunol Cell Biol. 2018 Jul 27. doi: 10.1111/imcb.12192. [Epub ahead of print]

PMID:
30051926
3.

Pivotal pathogenic and biomarker role of Chlamydia Pneumoniae in neurovascular diseases.

Richard SA.

Curr Neurovasc Res. 2018 Jul 17. doi: 10.2174/1567202615666180717161807. [Epub ahead of print]

PMID:
30019645
4.

Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis.

Tumurkhuu G, Dagvadorj J, Porritt RA, Crother TR, Shimada K, Tarling EJ, Erbay E, Arditi M, Chen S.

Cell Metab. 2018 Jun 18. pii: S1550-4131(18)30380-2. doi: 10.1016/j.cmet.2018.05.027. [Epub ahead of print]

PMID:
29937375
5.

Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.

Lantos I, Endrész V, Virok DP, Szabó A, Lu X, Mosolygó T, Burián K.

Biomed Res Int. 2018 Mar 25;2018:8325915. doi: 10.1155/2018/8325915. eCollection 2018.

6.

Identification of Chlamydia pneumoniae candidate genes that interact with human apoptotic factor caspase-9.

Aziz MA, Ushirokita R, Azuma Y.

J Gen Appl Microbiol. 2018 May 15. doi: 10.2323/jgam.2017.12.008. [Epub ahead of print]

7.

Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis.

Chen S, Shimada K, Crother TR, Erbay E, Shah PK, Arditi M.

J Am Coll Cardiol. 2018 Apr 10;71(14):1553-1570. doi: 10.1016/j.jacc.2018.01.072.

PMID:
29622163
8.

Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin.

Liu J, Miao G, Wang B, Zheng N, Ma L, Chen X, Wang G, Zhao X, Zhang L, Zhang L.

Biochem Biophys Res Commun. 2018 Mar 4;497(2):742-748. doi: 10.1016/j.bbrc.2018.02.145. Epub 2018 Feb 17.

PMID:
29462613
9.

Chlamydia pneumoniae exploits adipocyte lipid chaperone FABP4 to facilitate fat mobilization and intracellular growth in murine adipocytes.

Walenna NF, Kurihara Y, Chou B, Ishii K, Soejima T, Itoh R, Shimizu A, Ichinohe T, Hiromatsu K.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):353-359. doi: 10.1016/j.bbrc.2017.11.005. Epub 2017 Nov 3.

PMID:
29108997
10.

Lycopene Inhibits Propagation of Chlamydia Infection.

Zigangirova NA, Morgunova EY, Fedina ED, Shevyagina NV, Borovaya TG, Zhukhovitsky VG, Kyle NH, Petyaev IM.

Scientifica (Cairo). 2017;2017:1478625. doi: 10.1155/2017/1478625. Epub 2017 Aug 29.

11.

Detection of specific Chlamydia pneumoniae and cytomegalovirus antigens in human carotid atherosclerotic plaque in a Chinese population.

Cao J, Mao Y, Dong B, Guan W, Shi J, Wang S.

Oncotarget. 2017 Jul 18;8(33):55435-55442. doi: 10.18632/oncotarget.19314. eCollection 2017 Aug 15.

12.

The impact of pathogen burden on leukocyte telomere length in the Multi-Ethnic Study of Atherosclerosis.

Aiello AE, Jayabalasingham B, Simanek AM, Diez-Roux A, Feinstein L, Meier HCS, Needham BL, Dowd JB.

Epidemiol Infect. 2017 Oct;145(14):3076-3084. doi: 10.1017/S0950268817001881. Epub 2017 Sep 7.

PMID:
28879822
13.

Investigation of Chlamydia pneumoniae infection in Moroccan patients suffering from cardiovascular diseases.

Yazouli LE, Hejaji H, Elmdaghri N, Alami AA, Dakka N, Radouani F.

J Infect Public Health. 2018 Mar - Apr;11(2):246-249. doi: 10.1016/j.jiph.2017.07.029. Epub 2017 Aug 30.

14.

Iron Homeostasis in Tissues Is Affected during Persistent Chlamydia pneumoniae Infection in Mice.

Edvinsson M, Tallkvist J, Nyström-Rosander C, Ilbäck NG.

Biomed Res Int. 2017;2017:3642301. doi: 10.1155/2017/3642301. Epub 2017 Jun 13.

15.

Elevated sodium leads to the increased expression of HSP60 and induces apoptosis in HUVECs.

Jakic B, Buszko M, Cappellano G, Wick G.

PLoS One. 2017 Jun 12;12(6):e0179383. doi: 10.1371/journal.pone.0179383. eCollection 2017.

16.

In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil.

Freitas LS, Almeida NCC, Freitas Queiroz MA, Zaninotto MM, Fuzii HT, Ribeiro-Silva A, Vallinoto AC, Ishak MO, Quaresma JA, Ishak R.

Infect Drug Resist. 2017 Apr 10;10:109-114. doi: 10.2147/IDR.S123801. eCollection 2017.

17.

Molecular characterisation of Chlamydia pneumoniae associated to atherosclerosis.

El Yazouli L, Criscuolo A, Hejaji H, Bouazza M, Elmdaghri N, Aroussi Alami A, Amraoui A, Dakka N, Radouani F.

Pathog Dis. 2017 Jun 1;75(4). doi: 10.1093/femspd/ftx039.

PMID:
28387800
18.

Cholesterol uptake in the mouse aorta increases during Chlamydia pneumoniae infection.

Edvinsson M, Tallkvist J, Nyström-Rosander C, Ilbäck NG.

Pathog Dis. 2017 Jan 1;75(1). doi: 10.1093/femspd/ftx004.

PMID:
28158541
19.
20.

Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients.

Sessa R, Di Pietro M, Filardo S, Bressan A, Mazzuti L, Serafino S, Fantauzzi A, Turriziani O.

New Microbiol. 2017 Jan;40(1):33-37. Epub 2016 Nov 7.

Supplemental Content

Loading ...
Support Center